[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345294-105":59,"doc-detail-345294-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-inflammation-and-immune-regulation-in-chronic-inflammation-associated-cancers","Targeting Inflammation and Immune Regulation in Chronic Inflammation Associated Cancers","","Chronic inflammation drives cancer development by linking persistent immune activation to genomic instability, tissue microenvironment remodeling, and malignant transformation. In inflammation-associated malignancies such as colitis-associated cancer (CAC) and metabolic dysfunction–associated fatty liver disease–related hepatocellular carcinoma (MAFLD-HCC), sustained inflammatory signaling couples tissue injury with oncogenic pathways, enabling tumor initiation and progression. Prolonged preneoplastic stages also create windows for prevention and early interception. The review emphasizes convergent mechanisms (IL-6/STAT3, NF-κB, cytokine survival signaling) and impaired endogenous immunoregulation, highlighting TIPE2 as a key negative regulator whose reduced activity sustains tumor-promoting inflammation. ",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-inflammation-and-immune-regulation-in-chronic-inflammation-associated-cancers/345294/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-inflammation-and-immune-regulation-in-chronic-inflammation-associated-cancers/345294.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does chronic inflammation promote cancer development?","Question",{"text":112,"@type":113},"Chronic inflammation sustains immune activation, causes genomic instability, remodels the microenvironment, and supports malignant transformation through pro-growth inflammatory mediators.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which inflammation-associated cancers are discussed in the review?",{"text":117,"@type":113},"The review focuses on colitis-associated cancer (CAC) and metabolic dysfunction–associated fatty liver disease–related hepatocellular carcinoma (MAFLD-HCC) as representative inflammation-driven malignancies.",{"name":119,"@type":110,"acceptedAnswer":120},"What convergent signaling mechanisms are highlighted as shared between CAC and MAFLD-HCC?",{"text":121,"@type":113},"Shared mechanisms include IL-6/STAT3 and NF-κB activation, cytokine-driven survival signaling, and cooperation with genetic alterations such as APC, KRAS, and TP53.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345294,1790892588,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cancer Science  \nTargeting Inflammation and Immune Regulation in Chronic Inflammation Associated Cancers  \nLawan Rabiu  | Mengzhu Chinn | Feng Chen | Yerkezhan Yerkinkazhina | Yuan Tian | Wei-Guo Zhu  Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China  \nCorrespondence: Yuan Tian ([tianyuan1020@szu.edu.cn](tianyuan1020@szu.edu.cn)) | Wei-Guo Zhu ([zhuweiguo@szu.edu.cn](zhuweiguo@szu.edu.cn))  \nReceived: 31 December 2025 | Revised: 9 February 2026 | Accepted: 20 February 2026  \nKeywords: cancer | chronic inflammation | immune regulation | inflammation associated cancers | tumor microenvironment  \nABSTRACT  \nChronic inflammation is a fundamental driver of cancer development, linking persistent immune activation to genomic instability, microenvironmental remodeling, and malignant transformation. In inflammation-associated malignancies such ascolitis-associated cancer (CAC) and metabolic dysfunction–associated fatty liver disease–related hepatocellular carcinoma (MAFLD-HCC), sustained inflammatory signaling integrates tissue injury with oncogenic pathways to promote tumor initiation and progression. Importantly, these cancers arise through prolonged preneoplastic stages, during which dysregulated immune and inflammatory responses not only drive malignant transformation but also create opportunities for cancer prevention and early disease interception. CAC and MAFLD-HCC share convergent mechanisms, including IL-6/STAT3 and NF-κB activation, cytokine-driven survival signaling, and cooperation with genetic alterations in APC, KRAS, and TP53. A critical but often underappreciated dimension of this process is the failure of endogenous immunoregulatory systems that normally restrain excessive inflammation. Among these, the negative regulator of immune cells TIPE2 plays an important role in limiting inflammatory signaling, and its reduced activity contributes to the persistence of a tumor-promoting inflammatory microenvironment that supports both disease initiation and progression. This review synthesizes the shared inflammatory, immunologic, and microenvironmental mechanisms underpinning CAC and MAFLD-HCC, with a particular emphasis on how impaired immune regulation drives the transition from chronic inflammation to cancer. We further highlight therapeutic and preventive strategies targeting inflammation-driven pathways, underscoring the dual relevance of immune modulation for cancer prevention in chronic inflammatory disease and for the treatment of established malignancy.  \n1 | Introduction  \nChronic inflammation is a well-established driver of cancer initiation, promotion, and progression, acting through sustained  \nimmune activation, molecular reprogramming, and microenvironmental remodeling. Persistent inflammatory responses generate a tumor-promoting milieu enriched with cytokines, reactive oxygen species, and growth factors that induce genomic  \n\n| Abbreviations: APC, adenomatous polyposis coli; CAC, colitis-associated cancer; CAR, chimeric antigen receptor; CAR-T, chimeric antigen receptor T cell; CD, Crohn's disease; CRC, colorectal cancer; CRISPR/Cas9, clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9; CTL, cytotoxic T lymphocyte; DC, dendritic cell; ENS, enteric nervous system; FMT, fecal microbiota transplantation; G-CSF, granulocyte colony-stimulating factor; HCC, hepatocellular carcinoma; HDAC, histone deacetylase; HPA axis, hypothalamic–pituitary–adrenal axis; IACs, inflammation-associated cancers; IBD, inflammatory bowel disease; IL, interleukin; KRAS, Kirsten rat sarcoma viral oncogene homolog; LPS, lipopolysaccharide; MAFLD, metabolic dysfunction–associated fatty liver disease; MAFLD-HCC, metabolic dysfunction–associated fatty liver disease–related hepatocellular carcinoma; MASH, metabolic dysfunction–associated steatohepatitis; MDSCs, myeloid-derived suppressor cells; NF-κB, nuclear factor kappa B; PD-1, programmed cell death protein","cbCaiiEh8JePBAS4","https://ap.wps.com/l/cbCaiiEh8JePBAS4","pdf",3245573,14,"English","# Introduction\n## Chronic inflammation as a driver of cancer development\n## Inflammation-associated cancers and clinical relevance\n## Multistep progression and key inflammatory mediators","[{\"question\":\"How does chronic inflammation promote cancer development?\",\"answer\":\"Chronic inflammation sustains immune activation, causes genomic instability, remodels the microenvironment, and supports malignant transformation through pro-growth inflammatory mediators.\"},{\"question\":\"Which inflammation-associated cancers are discussed in the review?\",\"answer\":\"The review focuses on colitis-associated cancer (CAC) and metabolic dysfunction–associated fatty liver disease–related hepatocellular carcinoma (MAFLD-HCC) as representative inflammation-driven malignancies.\"},{\"question\":\"What convergent signaling mechanisms are highlighted as shared between CAC and MAFLD-HCC?\",\"answer\":\"Shared mechanisms include IL-6/STAT3 and NF-κB activation, cytokine-driven survival signaling, and cooperation with genetic alterations such as APC, KRAS, and TP53.\"}]","Targeting Inflammation and Immune Regulation in Chronic Inflammation Associated Cancers | PDF",1790057159,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ceb9b01a50911c2d5d6d0702c5d7a57.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7105e4d78bd0685467baeff92cd1fe2f.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14df9db9c2c557a8b1c5e80a0aa9be3a.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aedab96617151cc69182cb0000bf88c8.webp",980,1287]